 | • レポートコード：QYR2104Z2806 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、遺伝性がん検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（RNA検査、DNA検査）、用途別市場規模（乳がん、消化器がん、前立腺がん、呼吸器・肺がん、その他のがん）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・遺伝性がん検査の市場動向 ・企業の競争状況、市場シェア ・遺伝性がん検査の種類別市場規模（RNA検査、DNA検査） ・遺伝性がん検査の用途別市場規模（乳がん、消化器がん、前立腺がん、呼吸器・肺がん、その他のがん） ・遺伝性がん検査の北米市場規模2016-2027（アメリカ、カナダ） ・遺伝性がん検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・遺伝性がん検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・遺伝性がん検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・遺伝性がん検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Ambry Genetics (Konica Minota)、Asper Biogene、Natera、Caris Life Sciences、BioReference Laboratories (GeneDx)、LabSolutions、Progenity，Inc、ARUP Laboratories、NeoGenomics、Blueprint Genetics、CellMax Life、Fulgent Genetics、Myriad Genetics、Myogenes、LabCorp、Quest Diagnostics、Pathway Genomics、Strand Life Sciences） ・結論 |
Hereditary cancer testing is a process of identifying an inherited gene mutation that increases the risk of cancer development. It mainly includes predictive genetic testing and clinical DNA sequencing, in predictive genetic testing, patient’s family history is analyzed for any inherited mutation from ancestry. In DNA sequencing, entire DNA or genome of an individual is analyzed. It is useful for testing many genetic mutations at a time.
Market Analysis and Insights: Global Hereditary Cancer Testing Market
The global Hereditary Cancer Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hereditary Cancer Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hereditary Cancer Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hereditary Cancer Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hereditary Cancer Testing market.
Global Hereditary Cancer Testing Scope and Market Size
Hereditary Cancer Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hereditary Cancer Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
RNA Testing
DNA Testing
Segment by Application
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Ambry Genetics (Konica Minota)
Asper Biogene
Natera
Caris Life Sciences
BioReference Laboratories (GeneDx)
LabSolutions
Progenity，Inc
ARUP Laboratories
NeoGenomics
Caris Life Sciences
BioReference Laboratories (GeneDx)
Fulgent Genetics
Myriad Genetics
Myogenes
LabCorp
Quest Diagnostics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hereditary Cancer Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 RNA Testing
1.2.3 DNA Testing
1.3 Market by Application
1.3.1 Global Hereditary Cancer Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Breast Cancer
1.3.3 Gastrointestinal Cancer
1.3.4 Prostate Cancer
1.3.5 Respiratory/Lung Cancer
1.3.6 Other Cancers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hereditary Cancer Testing Market Perspective (2016-2027)
2.2 Hereditary Cancer Testing Growth Trends by Regions
2.2.1 Hereditary Cancer Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hereditary Cancer Testing Historic Market Share by Regions (2016-2021)
2.2.3 Hereditary Cancer Testing Forecasted Market Size by Regions (2022-2027)
2.3 Hereditary Cancer Testing Industry Dynamic
2.3.1 Hereditary Cancer Testing Market Trends
2.3.2 Hereditary Cancer Testing Market Drivers
2.3.3 Hereditary Cancer Testing Market Challenges
2.3.4 Hereditary Cancer Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hereditary Cancer Testing Players by Revenue
3.1.1 Global Top Hereditary Cancer Testing Players by Revenue (2016-2021)
3.1.2 Global Hereditary Cancer Testing Revenue Market Share by Players (2016-2021)
3.2 Global Hereditary Cancer Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hereditary Cancer Testing Revenue
3.4 Global Hereditary Cancer Testing Market Concentration Ratio
3.4.1 Global Hereditary Cancer Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hereditary Cancer Testing Revenue in 2020
3.5 Hereditary Cancer Testing Key Players Head office and Area Served
3.6 Key Players Hereditary Cancer Testing Product Solution and Service
3.7 Date of Enter into Hereditary Cancer Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hereditary Cancer Testing Breakdown Data by Type
4.1 Global Hereditary Cancer Testing Historic Market Size by Type (2016-2021)
4.2 Global Hereditary Cancer Testing Forecasted Market Size by Type (2022-2027)
5 Hereditary Cancer Testing Breakdown Data by Application
5.1 Global Hereditary Cancer Testing Historic Market Size by Application (2016-2021)
5.2 Global Hereditary Cancer Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Hereditary Cancer Testing Market Size (2016-2027)
6.2 North America Hereditary Cancer Testing Market Size by Type
6.2.1 North America Hereditary Cancer Testing Market Size by Type (2016-2021)
6.2.2 North America Hereditary Cancer Testing Market Size by Type (2022-2027)
6.2.3 North America Hereditary Cancer Testing Market Size by Type (2016-2027)
6.3 North America Hereditary Cancer Testing Market Size by Application
6.3.1 North America Hereditary Cancer Testing Market Size by Application (2016-2021)
6.3.2 North America Hereditary Cancer Testing Market Size by Application (2022-2027)
6.3.3 North America Hereditary Cancer Testing Market Size by Application (2016-2027)
6.4 North America Hereditary Cancer Testing Market Size by Country
6.4.1 North America Hereditary Cancer Testing Market Size by Country (2016-2021)
6.4.2 North America Hereditary Cancer Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Hereditary Cancer Testing Market Size (2016-2027)
7.2 Europe Hereditary Cancer Testing Market Size by Type
7.2.1 Europe Hereditary Cancer Testing Market Size by Type (2016-2021)
7.2.2 Europe Hereditary Cancer Testing Market Size by Type (2022-2027)
7.2.3 Europe Hereditary Cancer Testing Market Size by Type (2016-2027)
7.3 Europe Hereditary Cancer Testing Market Size by Application
7.3.1 Europe Hereditary Cancer Testing Market Size by Application (2016-2021)
7.3.2 Europe Hereditary Cancer Testing Market Size by Application (2022-2027)
7.3.3 Europe Hereditary Cancer Testing Market Size by Application (2016-2027)
7.4 Europe Hereditary Cancer Testing Market Size by Country
7.4.1 Europe Hereditary Cancer Testing Market Size by Country (2016-2021)
7.4.2 Europe Hereditary Cancer Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Hereditary Cancer Testing Market Size (2016-2027)
8.2 Asia-Pacific Hereditary Cancer Testing Market Size by Type
8.2.1 Asia-Pacific Hereditary Cancer Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hereditary Cancer Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hereditary Cancer Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Hereditary Cancer Testing Market Size by Application
8.3.1 Asia-Pacific Hereditary Cancer Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hereditary Cancer Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hereditary Cancer Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Hereditary Cancer Testing Market Size by Region
8.4.1 Asia-Pacific Hereditary Cancer Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hereditary Cancer Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Hereditary Cancer Testing Market Size (2016-2027)
9.2 Latin America Hereditary Cancer Testing Market Size by Type
9.2.1 Latin America Hereditary Cancer Testing Market Size by Type (2016-2021)
9.2.2 Latin America Hereditary Cancer Testing Market Size by Type (2022-2027)
9.2.3 Latin America Hereditary Cancer Testing Market Size by Type (2016-2027)
9.3 Latin America Hereditary Cancer Testing Market Size by Application
9.3.1 Latin America Hereditary Cancer Testing Market Size by Application (2016-2021)
9.3.2 Latin America Hereditary Cancer Testing Market Size by Application (2022-2027)
9.3.3 Latin America Hereditary Cancer Testing Market Size by Application (2016-2027)
9.4 Latin America Hereditary Cancer Testing Market Size by Country
9.4.1 Latin America Hereditary Cancer Testing Market Size by Country (2016-2021)
9.4.2 Latin America Hereditary Cancer Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hereditary Cancer Testing Market Size (2016-2027)
10.2 Middle East & Africa Hereditary Cancer Testing Market Size by Type
10.2.1 Middle East & Africa Hereditary Cancer Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hereditary Cancer Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hereditary Cancer Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Hereditary Cancer Testing Market Size by Application
10.3.1 Middle East & Africa Hereditary Cancer Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hereditary Cancer Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hereditary Cancer Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Hereditary Cancer Testing Market Size by Country
10.4.1 Middle East & Africa Hereditary Cancer Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hereditary Cancer Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Ambry Genetics (Konica Minota)
11.1.1 Ambry Genetics (Konica Minota) Company Details
11.1.2 Ambry Genetics (Konica Minota) Business Overview
11.1.3 Ambry Genetics (Konica Minota) Hereditary Cancer Testing Introduction
11.1.4 Ambry Genetics (Konica Minota) Revenue in Hereditary Cancer Testing Business (2016-2021)
11.1.5 Ambry Genetics (Konica Minota) Recent Development
11.2 Asper Biogene
11.2.1 Asper Biogene Company Details
11.2.2 Asper Biogene Business Overview
11.2.3 Asper Biogene Hereditary Cancer Testing Introduction
11.2.4 Asper Biogene Revenue in Hereditary Cancer Testing Business (2016-2021)
11.2.5 Asper Biogene Recent Development
11.3 Natera
11.3.1 Natera Company Details
11.3.2 Natera Business Overview
11.3.3 Natera Hereditary Cancer Testing Introduction
11.3.4 Natera Revenue in Hereditary Cancer Testing Business (2016-2021)
11.3.5 Natera Recent Development
11.4 Caris Life Sciences
11.4.1 Caris Life Sciences Company Details
11.4.2 Caris Life Sciences Business Overview
11.4.3 Caris Life Sciences Hereditary Cancer Testing Introduction
11.4.4 Caris Life Sciences Revenue in Hereditary Cancer Testing Business (2016-2021)
11.4.5 Caris Life Sciences Recent Development
11.5 BioReference Laboratories (GeneDx)
11.5.1 BioReference Laboratories (GeneDx) Company Details
11.5.2 BioReference Laboratories (GeneDx) Business Overview
11.5.3 BioReference Laboratories (GeneDx) Hereditary Cancer Testing Introduction
11.5.4 BioReference Laboratories (GeneDx) Revenue in Hereditary Cancer Testing Business (2016-2021)
11.5.5 BioReference Laboratories (GeneDx) Recent Development
11.6 LabSolutions
11.6.1 LabSolutions Company Details
11.6.2 LabSolutions Business Overview
11.6.3 LabSolutions Hereditary Cancer Testing Introduction
11.6.4 LabSolutions Revenue in Hereditary Cancer Testing Business (2016-2021)
11.6.5 LabSolutions Recent Development
11.7 Progenity，Inc
11.7.1 Progenity，Inc Company Details
11.7.2 Progenity，Inc Business Overview
11.7.3 Progenity，Inc Hereditary Cancer Testing Introduction
11.7.4 Progenity，Inc Revenue in Hereditary Cancer Testing Business (2016-2021)
11.7.5 Progenity，Inc Recent Development
11.8 ARUP Laboratories
11.8.1 ARUP Laboratories Company Details
11.8.2 ARUP Laboratories Business Overview
11.8.3 ARUP Laboratories Hereditary Cancer Testing Introduction
11.8.4 ARUP Laboratories Revenue in Hereditary Cancer Testing Business (2016-2021)
11.8.5 ARUP Laboratories Recent Development
11.9 NeoGenomics
11.9.1 NeoGenomics Company Details
11.9.2 NeoGenomics Business Overview
11.9.3 NeoGenomics Hereditary Cancer Testing Introduction
11.9.4 NeoGenomics Revenue in Hereditary Cancer Testing Business (2016-2021)
11.9.5 NeoGenomics Recent Development
11.10 Blueprint Genetics
11.10.1 Blueprint Genetics Company Details
11.10.2 Blueprint Genetics Business Overview
11.10.3 Blueprint Genetics Hereditary Cancer Testing Introduction
11.10.4 Blueprint Genetics Revenue in Hereditary Cancer Testing Business (2016-2021)
11.10.5 Blueprint Genetics Recent Development
11.11 CellMax Life
11.11.1 CellMax Life Company Details
11.11.2 CellMax Life Business Overview
11.11.3 CellMax Life Hereditary Cancer Testing Introduction
11.11.4 CellMax Life Revenue in Hereditary Cancer Testing Business (2016-2021)
11.11.5 CellMax Life Recent Development
11.12 Fulgent Genetics
11.12.1 Fulgent Genetics Company Details
11.12.2 Fulgent Genetics Business Overview
11.12.3 Fulgent Genetics Hereditary Cancer Testing Introduction
11.12.4 Fulgent Genetics Revenue in Hereditary Cancer Testing Business (2016-2021)
11.12.5 Fulgent Genetics Recent Development
11.13 Myriad Genetics
11.13.1 Myriad Genetics Company Details
11.13.2 Myriad Genetics Business Overview
11.13.3 Myriad Genetics Hereditary Cancer Testing Introduction
11.13.4 Myriad Genetics Revenue in Hereditary Cancer Testing Business (2016-2021)
11.13.5 Myriad Genetics Recent Development
11.14 Myogenes
11.14.1 Myogenes Company Details
11.14.2 Myogenes Business Overview
11.14.3 Myogenes Hereditary Cancer Testing Introduction
11.14.4 Myogenes Revenue in Hereditary Cancer Testing Business (2016-2021)
11.14.5 Myogenes Recent Development
11.15 LabCorp
11.15.1 LabCorp Company Details
11.15.2 LabCorp Business Overview
11.15.3 LabCorp Hereditary Cancer Testing Introduction
11.15.4 LabCorp Revenue in Hereditary Cancer Testing Business (2016-2021)
11.15.5 LabCorp Recent Development
11.16 Quest Diagnostics
11.16.1 Quest Diagnostics Company Details
11.16.2 Quest Diagnostics Business Overview
11.16.3 Quest Diagnostics Hereditary Cancer Testing Introduction
11.16.4 Quest Diagnostics Revenue in Hereditary Cancer Testing Business (2016-2021)
11.16.5 Quest Diagnostics Recent Development
11.17 Pathway Genomics
11.17.1 Pathway Genomics Company Details
11.17.2 Pathway Genomics Business Overview
11.17.3 Pathway Genomics Hereditary Cancer Testing Introduction
11.17.4 Pathway Genomics Revenue in Hereditary Cancer Testing Business (2016-2021)
11.17.5 Pathway Genomics Recent Development
11.18 Strand Life Sciences
11.18.1 Strand Life Sciences Company Details
11.18.2 Strand Life Sciences Business Overview
11.18.3 Strand Life Sciences Hereditary Cancer Testing Introduction
11.18.4 Strand Life Sciences Revenue in Hereditary Cancer Testing Business (2016-2021)
11.18.5 Strand Life Sciences Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Hereditary Cancer Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of RNA Testing
Table 3. Key Players of DNA Testing
Table 4. Global Hereditary Cancer Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Hereditary Cancer Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hereditary Cancer Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Hereditary Cancer Testing Market Share by Regions (2016-2021)
Table 8. Global Hereditary Cancer Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Hereditary Cancer Testing Market Share by Regions (2022-2027)
Table 10. Hereditary Cancer Testing Market Trends
Table 11. Hereditary Cancer Testing Market Drivers
Table 12. Hereditary Cancer Testing Market Challenges
Table 13. Hereditary Cancer Testing Market Restraints
Table 14. Global Hereditary Cancer Testing Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Hereditary Cancer Testing Market Share by Players (2016-2021)
Table 16. Global Top Hereditary Cancer Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereditary Cancer Testing as of 2020)
Table 17. Ranking of Global Top Hereditary Cancer Testing Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Hereditary Cancer Testing Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hereditary Cancer Testing Product Solution and Service
Table 21. Date of Enter into Hereditary Cancer Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hereditary Cancer Testing Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Hereditary Cancer Testing Revenue Market Share by Type (2016-2021)
Table 25. Global Hereditary Cancer Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Hereditary Cancer Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Hereditary Cancer Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Hereditary Cancer Testing Revenue Market Share by Application (2016-2021)
Table 29. Global Hereditary Cancer Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Hereditary Cancer Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Hereditary Cancer Testing Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Hereditary Cancer Testing Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Hereditary Cancer Testing Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Hereditary Cancer Testing Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Hereditary Cancer Testing Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Hereditary Cancer Testing Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Hereditary Cancer Testing Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Hereditary Cancer Testing Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Hereditary Cancer Testing Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Hereditary Cancer Testing Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Hereditary Cancer Testing Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Hereditary Cancer Testing Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Hereditary Cancer Testing Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Hereditary Cancer Testing Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Hereditary Cancer Testing Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Hereditary Cancer Testing Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Hereditary Cancer Testing Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Hereditary Cancer Testing Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Hereditary Cancer Testing Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Hereditary Cancer Testing Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Hereditary Cancer Testing Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Hereditary Cancer Testing Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Hereditary Cancer Testing Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Hereditary Cancer Testing Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Hereditary Cancer Testing Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Hereditary Cancer Testing Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Hereditary Cancer Testing Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Hereditary Cancer Testing Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Hereditary Cancer Testing Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Hereditary Cancer Testing Market Size by Country (2022-2027) & (US$ Million)
Table 61. Ambry Genetics (Konica Minota) Company Details
Table 62. Ambry Genetics (Konica Minota) Business Overview
Table 63. Ambry Genetics (Konica Minota) Hereditary Cancer Testing Product
Table 64. Ambry Genetics (Konica Minota) Revenue in Hereditary Cancer Testing Business (2016-2021) & (US$ Million)
Table 65. Ambry Genetics (Konica Minota) Recent Development
Table 66. Asper Biogene Company Details
Table 67. Asper Biogene Business Overview
Table 68. Asper Biogene Hereditary Cancer Testing Product
Table 69. Asper Biogene Revenue in Hereditary Cancer Testing Business (2016-2021) & (US$ Million)
Table 70. Asper Biogene Recent Development
Table 71. Natera Company Details
Table 72. Natera Business Overview
Table 73. Natera Hereditary Cancer Testing Product
Table 74. Natera Revenue in Hereditary Cancer Testing Business (2016-2021) & (US$ Million)
Table 75. Natera Recent Development
Table 76. Caris Life Sciences Company Details
Table 77. Caris Life Sciences Business Overview
Table 78. Caris Life Sciences Hereditary Cancer Testing Product
Table 79. Caris Life Sciences Revenue in Hereditary Cancer Testing Business (2016-2021) & (US$ Million)
Table 80. Caris Life Sciences Recent Development
Table 81. BioReference Laboratories (GeneDx) Company Details
Table 82. BioReference Laboratories (GeneDx) Business Overview
Table 83. BioReference Laboratories (GeneDx) Hereditary Cancer Testing Product
Table 84. BioReference Laboratories (GeneDx) Revenue in Hereditary Cancer Testing Business (2016-2021) & (US$ Million)
Table 85. BioReference Laboratories (GeneDx) Recent Development
Table 86. LabSolutions Company Details
Table 87. LabSolutions Business Overview
Table 88. LabSolutions Hereditary Cancer Testing Product
Table 89. LabSolutions Revenue in Hereditary Cancer Testing Business (2016-2021) & (US$ Million)
Table 90. LabSolutions Recent Development
Table 91. Progenity，Inc Company Details
Table 92. Progenity，Inc Business Overview
Table 93. Progenity，Inc Hereditary Cancer Testing Product
Table 94. Progenity，Inc Revenue in Hereditary Cancer Testing Business (2016-2021) & (US$ Million)
Table 95. Progenity，Inc Recent Development
Table 96. ARUP Laboratories Company Details
Table 97. ARUP Laboratories Business Overview
Table 98. ARUP Laboratories Revenue in Hereditary Cancer Testing Business (2016-2021) & (US$ Million)
Table 99. ARUP Laboratories Recent Development
Table 100. NeoGenomics Company Details
Table 101. NeoGenomics Business Overview
Table 102. NeoGenomics Hereditary Cancer Testing Product
Table 103. NeoGenomics Revenue in Hereditary Cancer Testing Business (2016-2021) & (US$ Million)
Table 104. NeoGenomics Recent Development
Table 105. Blueprint Genetics Company Details
Table 106. Blueprint Genetics Business Overview
Table 107. Blueprint Genetics Hereditary Cancer Testing Product
Table 108. Blueprint Genetics Revenue in Hereditary Cancer Testing Business (2016-2021) & (US$ Million)
Table 109. Blueprint Genetics Recent Development
Table 110. CellMax Life Company Details
Table 111. CellMax Life Business Overview
Table 112. CellMax Life Hereditary Cancer Testing Product
Table 113. CellMax Life Revenue in Hereditary Cancer Testing Business (2016-2021) & (US$ Million)
Table 114. CellMax Life Recent Development
Table 115. Fulgent Genetics Company Details
Table 116. Fulgent Genetics Business Overview
Table 117. Fulgent Genetics Hereditary Cancer Testing Product
Table 118. Fulgent Genetics Revenue in Hereditary Cancer Testing Business (2016-2021) & (US$ Million)
Table 119. Fulgent Genetics Recent Development
Table 120. Myriad Genetics Company Details
Table 121. Myriad Genetics Business Overview
Table 122. Myriad Genetics Hereditary Cancer Testing Product
Table 123. Myriad Genetics Revenue in Hereditary Cancer Testing Business (2016-2021) & (US$ Million)
Table 124. Myriad Genetics Recent Development
Table 125. Myogenes Company Details
Table 126. Myogenes Business Overview
Table 127. Myogenes Hereditary Cancer Testing Product
Table 128. Myogenes Revenue in Hereditary Cancer Testing Business (2016-2021) & (US$ Million)
Table 129. Myogenes Recent Development
Table 130. LabCorp Company Details
Table 131. LabCorp Business Overview
Table 132. LabCorp Hereditary Cancer Testing Product
Table 133. LabCorp Revenue in Hereditary Cancer Testing Business (2016-2021) & (US$ Million)
Table 134. LabCorp Recent Development
Table 135. Quest Diagnostics Company Details
Table 136. Quest Diagnostics Business Overview
Table 137. Quest Diagnostics Hereditary Cancer Testing Product
Table 138. Quest Diagnostics Revenue in Hereditary Cancer Testing Business (2016-2021) & (US$ Million)
Table 139. Quest Diagnostics Recent Development
Table 140. Pathway Genomics Company Details
Table 141. Pathway Genomics Business Overview
Table 142. Pathway Genomics Hereditary Cancer Testing Product
Table 143. Pathway Genomics Revenue in Hereditary Cancer Testing Business (2016-2021) & (US$ Million)
Table 144. Pathway Genomics Recent Development
Table 145. Strand Life Sciences Company Details
Table 146. Strand Life Sciences Business Overview
Table 147. Strand Life Sciences Hereditary Cancer Testing Product
Table 148. Strand Life Sciences Revenue in Hereditary Cancer Testing Business (2016-2021) & (US$ Million)
Table 149. Strand Life Sciences Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hereditary Cancer Testing Market Share by Type: 2020 VS 2027
Figure 2. RNA Testing Features
Figure 3. DNA Testing Features
Figure 4. Global Hereditary Cancer Testing Market Share by Application: 2020 VS 2027
Figure 5. Breast Cancer Case Studies
Figure 6. Gastrointestinal Cancer Case Studies
Figure 7. Prostate Cancer Case Studies
Figure 8. Respiratory/Lung Cancer Case Studies
Figure 9. Other Cancers Case Studies
Figure 10. Hereditary Cancer Testing Report Years Considered
Figure 11. Global Hereditary Cancer Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Hereditary Cancer Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Hereditary Cancer Testing Market Share by Regions: 2020 VS 2027
Figure 14. Global Hereditary Cancer Testing Market Share by Regions (2022-2027)
Figure 15. Global Hereditary Cancer Testing Market Share by Players in 2020
Figure 16. Global Top Hereditary Cancer Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereditary Cancer Testing as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Hereditary Cancer Testing Revenue in 2020
Figure 18. Global Hereditary Cancer Testing Revenue Market Share by Type (2016-2021)
Figure 19. Global Hereditary Cancer Testing Revenue Market Share by Type (2022-2027)
Figure 20. North America Hereditary Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Hereditary Cancer Testing Market Share by Type (2016-2027)
Figure 22. North America Hereditary Cancer Testing Market Share by Application (2016-2027)
Figure 23. North America Hereditary Cancer Testing Market Share by Country (2016-2027)
Figure 24. United States Hereditary Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Hereditary Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Hereditary Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Hereditary Cancer Testing Market Share by Type (2016-2027)
Figure 28. Europe Hereditary Cancer Testing Market Share by Application (2016-2027)
Figure 29. Europe Hereditary Cancer Testing Market Share by Country (2016-2027)
Figure 30. Germany Hereditary Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Hereditary Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Hereditary Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Hereditary Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Hereditary Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Hereditary Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Hereditary Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Hereditary Cancer Testing Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Hereditary Cancer Testing Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Hereditary Cancer Testing Market Share by Region (2016-2027)
Figure 40. China Hereditary Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Hereditary Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Hereditary Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Hereditary Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Hereditary Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Hereditary Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Hereditary Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Hereditary Cancer Testing Market Share by Type (2016-2027)
Figure 48. Latin America Hereditary Cancer Testing Market Share by Application (2016-2027)
Figure 49. Latin America Hereditary Cancer Testing Market Share by Country (2016-2027)
Figure 50. Mexico Hereditary Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Hereditary Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Hereditary Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Hereditary Cancer Testing Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Hereditary Cancer Testing Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Hereditary Cancer Testing Market Share by Country (2016-2027)
Figure 56. Turkey Hereditary Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Hereditary Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Hereditary Cancer Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Ambry Genetics (Konica Minota) Revenue Growth Rate in Hereditary Cancer Testing Business (2016-2021)
Figure 60. Asper Biogene Revenue Growth Rate in Hereditary Cancer Testing Business (2016-2021)
Figure 61. Natera Revenue Growth Rate in Hereditary Cancer Testing Business (2016-2021)
Figure 62. Caris Life Sciences Revenue Growth Rate in Hereditary Cancer Testing Business (2016-2021)
Figure 63. BioReference Laboratories (GeneDx) Revenue Growth Rate in Hereditary Cancer Testing Business (2016-2021)
Figure 64. LabSolutions Revenue Growth Rate in Hereditary Cancer Testing Business (2016-2021)
Figure 65. Progenity，Inc Revenue Growth Rate in Hereditary Cancer Testing Business (2016-2021)
Figure 66. ARUP Laboratories Revenue Growth Rate in Hereditary Cancer Testing Business (2016-2021)
Figure 67. NeoGenomics Revenue Growth Rate in Hereditary Cancer Testing Business (2016-2021)
Figure 68. Blueprint Genetics Revenue Growth Rate in Hereditary Cancer Testing Business (2016-2021)
Figure 69. CellMax Life Revenue Growth Rate in Hereditary Cancer Testing Business (2016-2021)
Figure 70. Fulgent Genetics Revenue Growth Rate in Hereditary Cancer Testing Business (2016-2021)
Figure 71. Myriad Genetics Revenue Growth Rate in Hereditary Cancer Testing Business (2016-2021)
Figure 72. Myogenes Revenue Growth Rate in Hereditary Cancer Testing Business (2016-2021)
Figure 73. LabCorp Revenue Growth Rate in Hereditary Cancer Testing Business (2016-2021)
Figure 74. Quest Diagnostics Revenue Growth Rate in Hereditary Cancer Testing Business (2016-2021)
Figure 75. Pathway Genomics Revenue Growth Rate in Hereditary Cancer Testing Business (2016-2021)
Figure 76. Strand Life Sciences Revenue Growth Rate in Hereditary Cancer Testing Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
世界の遺伝性がん検査市場規模・現状・予測（2021年-2027年） Hereditary cancer testing is a process of identifying an inherited gene mutation that increases the risk of cancer development. It mainly includes predictive genetic testing and clinical DNA sequencing, in predictive genetic testing, patient’s family history is analyzed for any inherited mutation fr…- 世界の前立腺がん検査市場規模・現状・予測（2021年-2027年） Prostate cancer testing refers to the tests conducted for the detection, localization, grading, and staging of prostate carcinoma. The currently established methods of prostate cancer detection include digital rectal examination (DRE), serum prostate-specific antigen (PSA) tests, and transrectal ult…
- 世界の乳がん予測遺伝子検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Breast Cancer Predictive Genetic Testing Market The global Breast Cancer Predictive Genetic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analys…
- 世界のがん検診/スクリーニング市場規模・現状・予測（2021年-2027年） Screening means checking your body for cancer before you have symptoms. In the recent years, Next Generation Sequencing (NGS) is being widely used for detection of various types of cancer. Market Analysis and Insights: Global Cancer Testing/Screening Market The global Cancer Testing/Screening market…
- 世界の甲状腺がん検査市場規模・現状・予測（2021年-2027年） Thyroid cancer is a type of cancer that occurs when abnormal cell begin to grow in thyroid gland, responsible for the excretion of thyroid hormones. The global thyroid cancer testing is expected to show significant growth over the forecast period. Increasing prevalence of thyroid cancer, technologic…